KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Other financing activities: 2018-2025

Historic Other financing activities for Guardant Health (GH) over the last 3 years, with Jun 2025 value amounting to $151,000.

  • Guardant Health's Other financing activities rose 134.47% to $151,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $12.3 million, marking a year-over-year increase of 3937.07%. This contributed to the annual value of -$153,000 for FY2024, which is 100.72% down from last year.
  • According to the latest figures from Q2 2025, Guardant Health's Other financing activities is $151,000, which was down 98.76% from $12.1 million recorded in Q1 2025.
  • Over the past 5 years, Guardant Health's Other financing activities peaked at $21.3 million during Q2 2023, and registered a low of -$1.7 million during Q4 2021.
  • Over the past 3 years, Guardant Health's median Other financing activities value was $105,000 (recorded in 2024), while the average stood at $3.3 million.
  • As far as peak fluctuations go, Guardant Health's Other financing activities crashed by 102.06% in 2024, and later soared by 4,622.96% in 2025.
  • Guardant Health's Other financing activities (Quarterly) stood at -$1.7 million in 2021, then spiked by 98.95% to -$18,000 in 2022, then soared by 3,727.78% to $653,000 in 2023, then slumped by 90.96% to $59,000 in 2024, then spiked by 134.47% to $151,000 in 2025.
  • Its Other financing activities was $151,000 in Q2 2025, compared to $12.1 million in Q1 2025 and $59,000 in Q4 2024.